Status:

WITHDRAWN

AV Fistula Salvage in Advanced CKD Using Sodium Bicarbonate Prophylaxis

Lead Sponsor:

MaineHealth

Conditions:

Acute Renal Failure

Eligibility:

All Genders

18+ years

Brief Summary

This is an observational study assessing the impact of conventional dose iodinated contrast on the renal function of advanced chronic kidney disease patients undergoing arteriovenous fistula evaluatio...

Detailed Description

The National Kidney Foundation publishes kidney disease outcome guidelines for improving care of the chronic kidney disease (CKD) patient. Regarding hemodialysis vascular access, the recommendation is...

Eligibility Criteria

Inclusion

  • English speaking
  • \>18 yrs age
  • chronic kidney disease, documented GFR\<30ml/min by abbreviated MDRD calculation

Exclusion

  • Inpatients
  • Pediatric patients
  • Non-English speaking patients
  • established dialysis patients
  • patients receiving iodinated contrast within 30 days of current procedure
  • patients with central arterial manipulation within 30 days of current procedure

Key Trial Info

Start Date :

January 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2009

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00621972

Start Date

January 1 2008

End Date

November 1 2009

Last Update

September 20 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maine Medical Center - Brighton Campus

Portland, Maine, United States, 04101

AV Fistula Salvage in Advanced CKD Using Sodium Bicarbonate Prophylaxis | DecenTrialz